NO TO HATTATSU
Online ISSN : 1884-7668
Print ISSN : 0029-0831
ISSN-L : 0029-0831
Short Communications
A national survey of adverse event for buccal midazolam as prehospital treatment
Madoka HoshideSeigo KorematsuSusumu ItoShoko ShimokawaRie MiyataSatoshi IharaMitsuko IshiiYoshihiro WatanabeMiho FukuiTatsuharu SatoNoriko MorimotoYusaku MiyamotoMasakazu MimakiGaku YamanakaHideo YamanouchiKazuhiro MuramatsuYasuhiro Takeshima
Author information
JOURNAL FREE ACCESS

2024 Volume 56 Issue 2 Pages 145-147

Details
Abstract

  A questionnaire survey was conducted among members of the Japanese Society of Pediatric Neurology regarding adverse events with oral solution of midazolam (buccal MDL) used as prehospital treatment for status epilepticus. A total of 431 respondents were surveyed (12.0% responded). Of 580 patients treated with buccal MDL, 14 (2.4%) had adverse events (respiratory depression, falls and trauma due to dizziness, sedation for more than 1 hour). 7 of the 14 cases were due to respiratory depression. Respiratory depression should be considered as an adverse event when buccal MDL is administered for status epilepticus.

Content from these authors
© 2024 The Japanese Society of Child Neurology
Previous article Next article
feedback
Top